Founder Dr. Jack A. Elias.
20/04/2023 13:07
April 20 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL (NASDAQ: OCEA) ANNOUNCES NOTICE OF
ALLOWANCE
FOR U.S. PATENT APPLICATION FOR BREAKTHROUGH PULMONARY FIBROSIS
TREATMENTS ISSUED TO SCIENTIFIC CO-FOUNDER DR. JACK A. ELIAS.
Source text for Eikon: ID:nGNXbJlThY
Further company coverage: OCEA.O
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26